ライフサイエンスコーパス: Staphylococcus aureus

1 t Escherichia coli and methicillin-resistant Staphylococcus aureus).

2 uman pathogens such as methicillin-resistant Staphylococcus aureus.

3 teria monocytogenes, Salmonella enterica and Staphylococcus aureus.

4 a of the reduced colonisation of implants by Staphylococcus aureus.

5 O had an antimicrobial activity against only Staphylococcus aureus.

6 ions of S100A8 or subcutaneous injections of Staphylococcus aureus.

7 as community-acquired methicillin-resistant Staphylococcus aureus.

8 for infections due to methicillin-resistant Staphylococcus aureus.

9 roduction in Group B Streptococcus (GBS) and Staphylococcus aureus.

10 nds were infected with methicillin-resistant Staphylococcus aureus.

11 bacter baumanii, Pseudomonas aeruginosa, and Staphylococcus aureus.

12 o have activity against Escherichia coli and Staphylococcus aureus.

13 infarction 365 days after blood culture for Staphylococcus aureus.

14 h community-associated methicillin-resistant Staphylococcus aureus.

15 cation characteristic for the human pathogen Staphylococcus aureus.

16 e organisms are Streptococcus pneumoniae and Staphylococcus aureus.

17 ing disease caused by superantigen-producing Staphylococcus aureus.

18 omyelitis, infective endocarditis) caused by Staphylococcus aureus.

19 f community-associated methicillin-resistant Staphylococcus aureus.

20 PiuA functions in the same way as SstD from Staphylococcus aureus.

21 ffender isolated from the PLA in children is Staphylococcus aureus.

22 um tuberculosis, Pseudomonas aeruginosa, and Staphylococcus aureus.

23 stridium difficile and methicillin-resistant Staphylococcus aureus.

24 ory cultures, the most common pathogens were Staphylococcus aureus (34%) and Pseudomonas aeruginosa (

25 The targets with a PPA of <100% were Staphylococcus aureus (34/37 [91.9%]), Streptococcus pne

26 e incident PJI was most frequently caused by Staphylococcus aureus (43%), followed by streptococci (2

27 ree urgent threat pathogens encompassing 288 Staphylococcus aureus, 456 Pseudomonas aeruginosa, and 1

28 Streptococcus pneumoniae (9/44 [20%]) and Staphylococcus aureus (7/14 [50%]) were the predominant

29 ved among patients with pneumonias caused by Staphylococcus aureus (90-day multivariable adjusted OR,

30 e pathogens, including methicillin-resistant Staphylococcus aureus, a common cause of human infection

31 uppresses its antimicrobial activity against Staphylococcus aureus, a common pathogen co-isolated wit

32 Staphylococcus aureus adhesion to the host's skin and mu

33 in hypertension, glaucoma, and responses to Staphylococcus aureus alpha-toxin.

34 , we elucidate why coccoid bacteria, such as Staphylococcus aureus, also possess two SEDS-bPBP pairs.

35 etection of the pathogenic bacterial species Staphylococcus aureus and antibiotic resistant Acinetoba

36 to interrogate the morphologically distinct Staphylococcus aureus and Bacillus subtilis species, usi

37 Staphylococcus aureus and Enterobacterales were the most

38 observed in less than half of patients, with Staphylococcus aureus and enterococcus bacteremia associ

39 Staphylococcus aureus and enterococcus had the highest 1

40 In IE cases treated with valve surgery, Staphylococcus aureus and Enterococcus spp. were associa

41 n of multidrug-resistant bacteria, including Staphylococcus aureus and Escherichia coli, leading to t

42 pecies (ROS) and the antimicrobial effect on Staphylococcus aureus and Escherichia coli.

43 Unit-level changes in methicillin-resistant Staphylococcus aureus and extended-spectrum beta lactama

44 ose in other Gram-positive pathogens such as Staphylococcus aureus and Listeria monocytogenes, DacA i

45 blood mononuclear cells were stimulated with Staphylococcus aureus and Mycobacterium tuberculosis bef

46 t attach virulence factors to the surface of Staphylococcus aureus and other medically significant ba

47 ly with their antibacterial activity against Staphylococcus aureus and Pseudomonas aeruginosa and wit

48 Staphylococcus aureus and Pseudomonas aeruginosa were is

49 gative and Gram-positive bacteria, including Staphylococcus aureus and Pseudomonas aeruginosa, and th

50 is essential for fatty acid biosynthesis in Staphylococcus aureus and represents a promising target

51 The most common implicated pathogens were Staphylococcus aureus and S. epidermidis.

52 Staphylococcus aureus and Staphylococcus epidermidis are

53 spp., Escherichia coli, Salmonella enterica, Staphylococcus aureus and Streptococcus pneumoniae were

54 dely used orthologs of Cas9 are derived from Staphylococcus aureus and Streptococcus pyogenes(5,7).

55 rate the sensor's specificity, tests against Staphylococcus aureus and Streptococcus uberis samples a

56 omodulatory RNA and DNA by pathogens such as Staphylococcus aureus and their delivery to intracellula

57 socomial pathogenic microorganisms including Staphylococcus aureus and two Candida strains.

58 th decreased capacity of neutrophils to kill Staphylococcus aureus and worse clinical outcomes.

59 ted bacterial clearance after infection with Staphylococcus aureus and, by licensing encephalitogenic

60 n model with heat-inactivated Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia co

61 am-positive (including methicillin-resistant Staphylococcus aureus) and gram-negative pathogens.

62 domonas fluorescens, Salmonella typhimurium, Staphylococcus aureus); and fungal enzymes under acid-st

63 nterobacter agglomerans, Pseudomonas putida, Staphylococcus aureus, and Bacillus subtilis was observe

64 cally related to the two binding proteins of Staphylococcus aureus, and biochemical and X-ray crystal

65 and saliva) and bacteria media (blank broth, Staphylococcus aureus, and E. coli).

66 pathogens, including Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli We have prev

67 ogens, including Mycobacterium tuberculosis, Staphylococcus aureus, and Escherichia coli, and identif

68 ed the risk of EOS by group B Streptococcus, Staphylococcus aureus, and Escherichia coli.

69 Cas9 nucleases from Streptococcus pyogenes, Staphylococcus aureus, and Francisella novicida complexe

70 titis (AD) patients are often colonized with Staphylococcus aureus, and staphylococcal biofilms have

71 microbial agents, anti-methicillin-resistant Staphylococcus aureus [anti-MRSA] agents, and antipseudo

72 Moreover, after epicutaneous Staphylococcus aureus application, impaired S1pr2(-/-) m

73 Intramammary infections (IMI) with Staphylococcus aureus are a common cause of bovine masti

74 Pseudomonas aeruginosa and Staphylococcus aureus are opportunistic bacterial pathog

75 , including major clinical pathogens such as Staphylococcus aureus, are becoming increasingly drug-re

76 22.8%) cultured SSTIs, 332 (66.0%) recovered Staphylococcus aureus as a pathogen, of which 287/332 (8

77 ocidin (Luk) exotoxins of the major pathogen Staphylococcus aureus as a prototype, we randomly fragme

78 esistant strains, like methicillin-resistant Staphylococcus aureus, as well as Yersinia pestis and Ba

79 vity against Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 29213, while DMPD chemilumine

80 of 0.024 ug/mL against methicilin resistant Staphylococcus aureus ATCC 43300 and Candida albicans MT

81 Staphylococcus aureus bacteraemia (SAB) is associated wi

82 ctive, matched cohort study of patients with Staphylococcus aureus bacteremia (SAB) and gram-negative

83 ukin (IL)-1beta and IL-10 responses early in Staphylococcus aureus bacteremia (SaB) are associated wi

84 Staphylococcus aureus bacteremia (SaB) causes significan

85 Persistent Staphylococcus aureus bacteremia (SAB) is defined based

86 Staphylococcus aureus bacteremia (SAB) is uniquely chara

87 effectiveness was measured by the numbers of Staphylococcus aureus bacteremia (SAB), Clostridium diff

88 itis (IE) is the most feared complication of Staphylococcus aureus bacteremia (SAB).

89 e skin and skin structure infections (SSSI), Staphylococcus aureus bacteremia, and right-sided endoca

90 Understanding the changing epidemiology of Staphylococcus aureus bacteremia, as well as the variabl

91 effectiveness was measured by the numbers of Staphylococcus aureus bacteremia, Clostridium difficile

92 ptic shock and 2) hospitalized patients with Staphylococcus aureus bacteremia.

93 en examined among patients specifically with Staphylococcus aureus bacteremia.

94 eudomonas aeruginosa and Gram stain-positive Staphylococcus aureus bacteria, inducing 95 +/- 5% and 8

95 etiologic agent, the Gram-positive bacterium Staphylococcus aureus Bacterial osteomyelitis triggers p

96 ss than 1 mum diameter) and nearly spherical Staphylococcus aureus bacterium.

97 y examined antibody-based assays against the Staphylococcus aureus biofilm-upregulated antigens SAOCO

98 The virulence mechanisms associated with Staphylococcus aureus biofilms are becoming better under

99 m activity of D-Asp and D-Glu was studied on Staphylococcus aureus biofilms.

100 sessed the association of Community acquired Staphylococcus aureus bloodstream infection (CA-SABSI) w

101 apeutic approaches are critically needed for Staphylococcus aureus bloodstream infections (BSIs), par

102 t the purified Tet38 membrane transporter of Staphylococcus aureus bound specifically to host cell CD

103 Selection pressures exerted on Staphylococcus aureus by host factors during infection m

104 t Escherichia coli and methicillin-resistant Staphylococcus aureus by recognizing corresponding antim

105 Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is threatening public he

106 h community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) SSTI, their household co

107 by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).

108 ker-attached trisaccharide repeating unit of Staphylococcus aureus capsular polysaccharide type 5, wh

109 This study investigated Staphylococcus aureus carriage in patients with microbia

110 CRISPR-Staphylococcus aureus Cas9 (CRISPR-SaCas9) has been harn

111 To identify Acrs capable of inhibiting Staphylococcus aureus Cas9 (SauCas9), an alternative to

112 In Staphylococcus aureus-caused endocarditis, the pathogen

113 Here, we show that a Staphylococcus aureus cell wall hydrolase and a membrane

114 manner using wild-type Escherichia coli and Staphylococcus aureus cells at variable levels of target

115 cteria, including 8/60 (13.3%) patients with Staphylococcus aureus Chronic tissue infection with S. a

116 py in dairy cows with experimentally induced Staphylococcus aureus clinical mastitis.

117 In Staphylococcus aureus, CntM catalyzes the last biosynthe

118 To determine the effects of dupilumab on Staphylococcus aureus colonization and microbial diversi

119 and adhesin genes, which, in turn, promotes Staphylococcus aureus colonization.

120 isition system in the opportunistic pathogen Staphylococcus aureus comprises nine proteins, called ir

121 d cells showed defective in vitro killing of Staphylococcus aureus, consistent with a specific granul

122 n MGE that confers methicillin resistance to Staphylococcus aureus, creating MRSA strains.

123 tection (316 copies of methicillin-resistant Staphylococcus aureus DNA) in our lab's "MD NAAT" platfo

124 as Escherichia coli O157, Listeria innocua, Staphylococcus aureus, Enterococcus faecalis, and Bacill

125 Staphylococcus aureus, especially highly pathogenic comm

126 a or bacterial (Streptococcus pneumoniae and Staphylococcus aureus) etiologies and compared with heal

127 t several streptogramin-resistant strains of Staphylococcus aureus, exhibits decreased rates of acety

128 Staphylococcus aureus fatty acid kinase FakA is necessar

129 A Staphylococcus aureus gene (Sa0102) is predicted to enco

130 roach is sensitive to detecting as few as 17 Staphylococcus aureus genomes from a background of 100 n

131 ology of the major human and animal pathogen Staphylococcus aureus has been greatly enhanced by techn

132 Staphylococcus aureus has two binding proteins, whereas

133 be infected with Chlamydophila pneumoniae or Staphylococcus aureus, have received antibacterial drug

134 Previously, we determined the Staphylococcus aureus HSP ClpC temporally alters bacteri

135 ificity produced by the pathogenic bacterium Staphylococcus aureus identifies two positions that cont

136 Members of the EAP family of Staphylococcus aureus immune evasion proteins potently i

137 target in 117/200 (58.5%) samples, including Staphylococcus aureus in 22% of samples and Haemophilus

138 eviously been shown to have efficacy against Staphylococcus aureus in in vitro and in vivo models of

139 or gammadelta T cells to mediate immunity to Staphylococcus aureus in multiple tissue settings by the

140 iated pneumonia due to methicillin-resistant Staphylococcus aureus in rats.

141 The detection of Staphylococcus aureus in the concentration range from 50

142 and, finally, on the role of eosinophils and Staphylococcus aureus in the persistence of disease.

143 Multi-drug resistant Staphylococcus aureus, including methicillin-resistant S

144 hile ex vivo Mycobacterium tuberculosis- and Staphylococcus aureus-induced cytokine responses in peri

145 ed healing in ischemic methicillin-resistant Staphylococcus aureus infected delayed healing wounds in

146 study have identified an association between Staphylococcus aureus infection and acute myocardial inf

147 Using intravital microscopy, we found that Staphylococcus aureus infection induced neutrophil recru

148 as been implicated in host defense following Staphylococcus aureus infection, but precise mechanisms

149 ong all IE-SUD hospitalizations, 50.3% had a Staphylococcus aureus infection, compared with 19.4% of

150 in increased inflammation and mortality upon Staphylococcus aureus infection, recapitulating the huma

151 and a reduction in swarm formation following Staphylococcus aureus infection.

152 one marrow that is most commonly caused by a Staphylococcus aureus infection.

153 ds demonstrated cidality in a mouse model of Staphylococcus aureus infection.

154 Staphylococcus aureus infections can lead to diseases th

155 increased owing to a surge in drug-resistant Staphylococcus aureus infections, both in the hospital a

156 regulator (sarA) plays an important role in Staphylococcus aureus infections, including osteomyeliti

157 ng treated for serious methicillin-resistant Staphylococcus aureus infections.

158 cillin-susceptible and methicillin-resistant Staphylococcus aureus infections.

159 Staphylococcus aureus is a common pathogen causing infec

160 Staphylococcus aureus is a Gram-positive bacterium respo

161 Staphylococcus aureus is a Gram-positive opportunistic p

162 Staphylococcus aureus is a leading cause of bacterial pn

163 Staphylococcus aureus is a leading cause of biofilm-asso

164 Staphylococcus aureus is a leading cause of biofilm-asso

165 Staphylococcus aureus is a leading cause of both acute a

166 Staphylococcus aureus is a leading cause of health care-

167 Staphylococcus aureus is a leading cause of healthcare-

168 Staphylococcus aureus is a leading cause of pneumonia.

169 Staphylococcus aureus is a major human pathogen of the s

170 Staphylococcus aureus is a major human pathogen that cau

171 Staphylococcus aureus is a major human pathogen, and the

172 heat-shock GTPase HflX in the human pathogen Staphylococcus aureus is a minor disassembly factor.

173 Staphylococcus aureus is a significant human pathogen du

174 Staphylococcus aureus is also a "high priority" pathogen

175 Staphylococcus aureus is among the leading causes of bac

176 Staphylococcus aureus is an extremely infectious and mal

177 Staphylococcus aureus is an important bacterial pathogen

178 Staphylococcus aureus is an important human bacterial pa

179 Staphylococcus aureus is an opportunistic pathogen that

180 Moreover, we show that relative abundance of Staphylococcus aureus is associated with disease severit

181 The bacterial pathogen Staphylococcus aureus is capable of infecting a broad sp

182 Staphylococcus aureus is generally thought to divide in

183 Staphylococcus aureus is one of the four most prevalent

184 Staphylococcus aureus is responsible for various disease

185 The pathogenesis of Staphylococcus aureus is thought to depend on the produc

186 The Gram-positive bacterium, Staphylococcus aureus, is a versatile pathogen that can

187 Examples including Staphylococcus aureus isolates, gut metagenomes, and met

188 n of ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobac

189 was also analyzed for Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobac

190 Staphylococcus aureus, known to induce IFN production, c

191 Staphylococcus aureus lacking this protease is attenuate

192 Staphylococcus aureus, like all bacterial pathogens, use

193 n addition, we found that IL-4 and IL-13 and Staphylococcus aureus lipoteichoic acid work in combinat

194 tonitis, enteritis, and pneumonia induced by Staphylococcus aureus, Listeria monocytogenes, Escherich

195 H and skin microbiome dysbiosis, due to high Staphylococcus aureus loads, especially during flares.

196 ntimicrobial activity against multiresistant Staphylococcus aureus MIC = 5 mg/mL) and no cytotoxicity

197 st Pseudomonas aeruginosa (MIC 16 ug/mL) and Staphylococcus aureus (MIC 64 ug/mL).

198 hese were extracts of Zanthoxylum chalybeum (Staphylococcus aureus: MIC: 16 mug/mL; Enterococcus faec

199 e were inoculated with methicillin-resistant Staphylococcus aureus (MRSA) and a Kirschner wire (K-wir

200 vitro activity against methicillin-resistant Staphylococcus aureus (MRSA) and bolsters the innate imm

201 Methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile i

202 tant organisms such as methicillin-resistant Staphylococcus aureus (MRSA) and other healthcare-associ

203 CCN1 opsonizes methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa

204 r has activity against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant En

205 Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated wi

206 comes in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia.

207 erial activity against methicillin-resistant Staphylococcus aureus (MRSA) bacterial strain.

208 ted to be effective in Methicillin-resistant Staphylococcus aureus (MRSA) elimination.

209 d minimize toxicity in methicillin-resistant Staphylococcus aureus (MRSA) for various infections, the

210 enomic surveillance of methicillin-resistant Staphylococcus aureus (MRSA) identifies unsuspected tran

211 , we isolated EVs from methicillin-resistant Staphylococcus aureus (MRSA) in an environment with or w

212 y facilitate spread of methicillin-resistant Staphylococcus aureus (MRSA) in urban areas.

213 Postinfluenza methicillin-resistant Staphylococcus aureus (MRSA) infection can quickly devel

214 Methicillin-resistant Staphylococcus aureus (MRSA) infections cause significan

215 vention and control of methicillin-resistant Staphylococcus aureus (MRSA) infections remain challengi

216 ately needed to combat methicillin-resistant Staphylococcus aureus (MRSA) infections.

217 Methicillin-resistant Staphylococcus aureus (MRSA) is a common cause of health

218 Treatment of suspected methicillin-resistant Staphylococcus aureus (MRSA) is a cornerstone of many an

219 Methicillin-resistant Staphylococcus aureus (MRSA) is an important cause of ve

220 Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most successf

221 n networks.We examined methicillin-resistant Staphylococcus aureus (MRSA) isolates to determine if th

222 clinical sequencing of methicillin-resistant Staphylococcus aureus (MRSA) isolates.

223 treatments in killing methicillin-resistant Staphylococcus aureus (MRSA) persisters.

224 ption of high facility methicillin-resistant Staphylococcus aureus (MRSA) prevalence-not MRSA coloniz

225 orts suggested that US methicillin-resistant Staphylococcus aureus (MRSA) strain epidemiology has cha

226 e and dissemination of methicillin-resistant Staphylococcus aureus (MRSA) strains poses a major threa

227 ted emergence of novel methicillin resistant Staphylococcus aureus (MRSA) strains.

228 gene cycA resensitized methicillin-resistant Staphylococcus aureus (MRSA) to beta-lactam antibiotics.

229 Live methicillin-resistant Staphylococcus aureus (MRSA) was inoculated into the tai

230 rial pathogens such as methicillin-resistant Staphylococcus aureus (MRSA)(1-3).

231 ococcus aureus (MSSA), methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enter

232 584) were surveyed for methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enter

233 t infections caused by methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enter

234 e primarily focused on methicillin-resistant Staphylococcus aureus (MRSA).

235 tionship (SAR) against methicillin-resistant Staphylococcus aureus (MRSA).

236 bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA).

237 rly deescalation for methicillin-susceptible Staphylococcus aureus (MSSA) (19/24 [79%]) and avoidance

238 ditis) of persistent methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia, including immed

239 tic-resistant species [methicillin-sensitive Staphylococcus aureus (MSSA), methicillin-resistant Stap

240 tly reduce bacterial loads in a high-density Staphylococcus aureus murine skin infection model.

241 Here, we study the Staphylococcus aureus NanK (SaNanK), which is the first

242 Clinically important Staphylococcus aureus obtains iron by extracting heme fr

243 In Staphylococcus aureus, pentaglycine cross-bridges are sy

244 When applied to wild-type Staphylococcus aureus, PETRI-seq revealed a rare subpopu

245 ts relationship with the nicking activity of Staphylococcus aureus plasmid pT181 initiator RepC.

246 Infections caused by Staphylococcus aureus pose a serious and sometimes fatal

247 ts and Main Results: Haemophilus influenzae, Staphylococcus aureus, Pseudomonas aeruginosa, and Asper

248 PSOP displayed inhibitory activity against Staphylococcus aureus, Pseudomonas aeruginosa, and Enter

249 er, as well as its evaluation in PDI against Staphylococcus aureus, Pseudomonas aeruginosa, and Esche

250 not part of routine empiric coverage (e.g., Staphylococcus aureus, Pseudomonas aeruginosa, Clostridi

251 ective ability of the opportunistic pathogen Staphylococcus aureus, recognized as the most frequent c

252 Staphylococcus aureus relies on quorum sensing to exert

253 Staphylococcus aureus remains a leading cause of human i

254 del membranes and Pseudomonas aeruginosa and Staphylococcus aureus, representing Gram-positive and Gr

255 Here we describe the binding mode of Staphylococcus aureus RsfS to the large ribosomal subuni

256 Using Staphylococcus aureus ( S. aureus) as a test case, integ

257 Staphylococcus aureus (S. aureus) is a common colonizer

258 eting the femA or lytA gene for detection of Staphylococcus aureus (S. aureus) or Streptococcus pneum

259 ethod against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), which decreased first

260 ed that the adaptive immune response against Staphylococcus aureus (SA) skin infection substantially

261 Persistent bacteremia caused by Staphylococcus aureus (SA), especially methicillin-resis

262 The Small Colony Variant Staphylococcus aureus (SCVSA) study was a 2-year longitu

263 Most other bacterial pathogens, including Staphylococcus aureus, secrete numerous toxins and evolv

264 in vivo that early activation of Treg during Staphylococcus aureus sepsis induces CD4+ T-cell impairm

265 emolysin is critical for the pathogenesis of Staphylococcus aureus skin and soft tissue infection.

266 sex differences in innate susceptibility to Staphylococcus aureus skin infection and that bone marro

267 Staphylococcus aureus small colony variants (SCVs) are f

268 e evaluated the use of different variants of Staphylococcus aureus sortase A for a range of ligation

269 Testing of staphylococci other than Staphylococcus aureus (SOSA) for mecA-mediated resistanc

270 c activity of chromate reductase, NfoR, from Staphylococcus aureus sp. LZ-01 was augmented 1.5-fold b

271 Staphylococcus aureus ST45 is a major global MRSA lineag

272 ter baumannii, Stenotrophomonas maltophilia, Staphylococcus aureus, Staphylococcus epidermidis and St

273 , Enterococcus faecium, Staphylococcus spp., Staphylococcus aureus, Staphylococcus epidermidis, Staph

274 A Staphylococcus aureus strain deleted for the c-di-AMP cy

275 ers to analyze the phage-host interaction of Staphylococcus aureus strain FS159 with a virulent phage

276 ity was evaluated against the multiresistant Staphylococcus aureus strain USA300 for which they displ

277 a community-associated methicillin-resistant Staphylococcus aureus strain were internalized into huma

278 secretion system (T7SS) is conserved across Staphylococcus aureus strains and plays important roles

279 Staphylococcus aureus strains carrying enterotoxin A gen

280 Staphylococcus aureus strains showing higher relative bi

281 ated the utility of the Python package using Staphylococcus aureus strains that are resistant to vari

282 Recently, studies on bacteria such as Staphylococcus aureus, Streptococcus spp., Bacillus subt

283 lytic activity of Cd-SrtB and also SrtB from Staphylococcus aureus The serine residue indispensable f

284 In Staphylococcus aureus, the peptidoglycan assembly enzyme

285 o achieve effective tools that fight against Staphylococcus aureus, the results have not been success

286 In Staphylococcus aureus, the transcription factor CodY mod

287 orter, PstSCAB, increases the sensitivity of Staphylococcus aureus to calprotectin-mediated manganese

288 The ability of Staphylococcus aureus to infect many different tissue si

289 The Staphylococcus aureus type VII secretion system (T7SS) e

290 , Streptococcus pneumoniae serotype 12F, and Staphylococcus aureus types 5 and 8 capsular polysacchar

291 Here, we analyze genomic sequences of Staphylococcus aureus USA300 isolates from the same geog

292 If methicillin-resistant Staphylococcus aureus was suspected, either linezolid or

293 Staphylococcus aureus was the most common pathogen (53%)

294 bacterial 14TM helix transporter, NorC, from Staphylococcus aureus We identified this antibody in a y

295 erium tuberculosis, Salmonella enterica, and Staphylococcus aureus, we report that it is possible to

296 Among Gram-positive bacteria, Staphylococcus aureus were predominant.

297 (LukED) is a pore-forming toxin produced by Staphylococcus aureus, which lyses host cells and promot

298 challenging a diverse set of 222 isolates of Staphylococcus aureus with the antibiotic ciprofloxacin

299 hia coli (UPEC), Pseudomonas aeruginosa, and Staphylococcus aureus, with up to 3.7 logs of biomass re

300 observation of intracellular localization of Staphylococcus aureus within mast cells in nasal polyps.